Search Results - "Thethi, Tina"

Efficacy, safety and cardiovascular outcomes of once‐daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme by Thethi, Tina K., Pratley, Richard, Meier, Juris J.

“…Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are recommended for glycaemic management in patients with type 2 diabetes (T2D). Oral semaglutide, the…”
Get full text

Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus by Shi, Qian, Liu, Shuqian, Fonseca, Vivian A, Thethi, Tina K, Shi, Lizheng

“…ObjectiveThis study aimed to evaluate the association between metformin treatment and the risk of neurodegenerative disease (ND) among elderly adults with type…”
Get full text

Vasoactive mediators of hypertension in obesity by Ghanim, Husam, Thethi, Tina K, Abuaysheh, Sanaa, Fonseca, Vivian, Dandona, Paresh

“…Obesity is associated with hypertension. However, the mechanisms involved are not fully understood. Therefore, we investigated the relationship between obesity…”
Get more information

Challenging the conventional wisdom on diabetic nephropathy: Is microalbuminuria the earliest event? by Thethi, Tina K., Batuman, Veichi

“…Microalbuminuria, urine albumin-to-creatinine ratio >30 and less than <300 mg/g has widely been accepted as biomarker of early diabetic kidney disease (DKD)…”
Get full text

Weight Loss in Underserved Patients — A Cluster-Randomized Trial by Katzmarzyk, Peter T, Martin, Corby K, Newton, Robert L, Apolzan, John W, Arnold, Connie L, Davis, Terry C, Price-Haywood, Eboni G, Denstel, Kara D, Mire, Emily F, Thethi, Tina K, Brantley, Phillip J, Johnson, William D, Fonseca, Vivian, Gugel, Jonathan, Kennedy, Kathleen B, Lavie, Carl J, Sarpong, Daniel F, Springgate, Benjamin

“…In this cluster-randomized trial, carried out in an underserved population, the authors hypothesized that a high-intensity lifestyle intervention would result…”
Get full text

Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 Diabetes by KELLY, Tanika N, BAZZANO, Lydia A, FONSECA, Vivian A, THETHI, Tina K, REYNOLDS, Kristi, JIANG HE

“…Results from clinical trials examining the effect of intensive glucose control on cardiovascular disease have been conflicting. To summarize clinical benefits…”
Get full text

Cardiovascular Outcome Trials with Glucose-Lowering Drugs by Thethi, Tina K., Bilal, Anika, Pratley, Richard E.

“…Purpose of Review This review summarizes recent cardiovascular outcome trials (CVOTs) with glucose-lowering drugs. Recent Findings The majority of recent CVOTs…”
Get full text

423-P: Urinary Extracellular Vesicles in African Americans with Chronic Kidney Disease With and Without Type 2 Diabetes Mellitus by THETHI, TINA K., BILAL, ANIKA, ZAINO, MATTHEW S., ILIUK, ANTON, PRATLEY, RICHARD E., NUNEZ LOPEZ, YURY O.

“…Introduction: Type 2 diabetes (T2D) is the leading cause for chronic kidney disease (CKD). Novel biomarkers are critical in early detection of CKD. Methods:…”
Get full text

Initial weight loss and early intervention adherence predict long‐term weight loss during the Promoting Successful Weight Loss in Primary Care in Louisiana lifestyle intervention by Höchsmann, Christoph, Martin, Corby K., Apolzan, John W., Dorling, James L., Newton, Robert L., Denstel, Kara D., Mire, Emily F., Johnson, William D., Zhang, Dachuan, Arnold, Connie L., Davis, Terry C., Fonseca, Vivian, Thethi, Tina K., Lavie, Carl J., Springgate, Benjamin, Katzmarzyk, Peter T.

“…Objective This study tested whether initial weight change (WC), self‐weighing, and adherence to the expected WC trajectory predict longer‐term WC in an…”
Get full text

Effects of newer anti-hyperglycemic agents on cardiovascular outcomes in older adults: Systematic review and meta-analysis by Bilal, Anika, Yi, Fanchao, Gonzalez, Gonzalo Romero, Ali, Mehreen, Im, KyungAh, Ruff, Christian T., Thethi, Tina K., Pratley, Richard E.

“…To demonstrate cardiovascular safety of dipeptidyl peptidase-4 inhibitors (DPP-4i), glucagon-like peptide-1 receptor agonists (GLP-1RA), and sodium/glucose…”
Get full text

Metanx in Type 2 Diabetes with Peripheral Neuropathy: A Randomized Trial by Fonseca, Vivian A., MD, Lavery, Lawrence A., DPM, MPH, Thethi, Tina K., MD, Daoud, Yahya, PhDC, DeSouza, Cyrus, MD, Ovalle, Fernando, MD, Denham, Douglas S., DO, Bottiglieri, Teodoro, PhD, Sheehan, Peter, MD, Rosenstock, Julio, MD

“…Abstract Purpose To determine whether a combination of L-methylfolate, methylcobalamin, and pyridoxal-5′-phosphate (LMF-MC-PLP [Metanx; Pamlab LLC, Covington,…”
Get full text

Predictors of racial differences in weight loss: the PROPEL trial by Newton, Robert L., Zhang, Dachaun, Johnson, William D., Martin, Corby K., Apolzan, John W., Denstel, Kara D., Brantley, Phillip J., Davis, Terry C., Arnold, Connie, Sarpong, Daniel F., Price‐Haywood, Eboni G., Lavie, Carl J., Thethi, Tina K., Katzmarzyk, Peter T.

“…Objective Studies have consistently shown that African American individuals lose less weight in response to behavioral interventions, but the mechanisms…”
Get full text

Racial and sex differences in the polymorphisms of the endocannabinoid receptor genes in obesity by Thethi, Tina K., Sigel, Aster, Japa, Shanker, Katalenich, Bonnie, Liu, Shuqian, Nguyen, Tuyen, Larrazolo, Joshua, Syu, Stephanie, Carefoot, Esther, McDuffie, Roberta, Fonseca, Vivian

“…Obesity is a global epidemic and prevalence of obesity is higher in African Americans (AAs) compared to Caucasians. The endocannabinoid system (EC) and…”
Get full text

Cardiovascular Outcomes Trials of Incretin-Based Therapies by Thethi, Tina K., Bilal, Anika, Pratley, Richard E.

“…The cardiovascular (CV) safety of glucagon-like peptide 1 (GLP-1) receptor agonists has been established in robust cardiovascular outcomes trials (CVOTs) in…”
Get full text

Patient-centered assessment on disease burden, quality of life, and treatment satisfaction associated with acromegaly by Liu, Shuqian, Adelman, Daphne T, Xu, Yaping, Sisco, Jillone, Begelman, Susan M, Webb, Susan M, Badia, Xavier, Thethi, Tina K, Fonseca, Vivian, Shi, Lizheng

“…The study aimed to assess the economic burden, health-related quality of life (HRQoL), and acromegaly treatment satisfaction in the USA. A web-based,…”
Get full text

Physical activity and weight loss in a pragmatic weight loss trial by Katzmarzyk, Peter T., Mire, Emily F., Martin, Corby K., Newton, Robert L., Apolzan, John W., Denstel, Kara D., Johnson, William D.

“…The purpose of this study was to determine the association between changes in physical activity and changes in body weight in a cluster-randomized weight loss…”
Get full text

Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease by Thethi, Tina K, Bajwa, Muhammad A, Ghanim, Husam, Jo, Chanhee, Weir, Monica, Goldfine, Allison B, Umpierrez, Guillermo, Desouza, Cyrus, Dandona, Paresh, Fang-Hollingsworth, Ying, Raghavan, Vasudevan, Fonseca, Vivian A

“…Abstract Aims Patients with type 2 diabetes (T2DM) and chronic kidney disease (CKD) have impaired endothelial function. Vitamin D and its analogs may play a…”
Get full text

The Effect of Liraglutide on 24-Hour Ambulatory Blood Pressure in Patients with T2DM—A Pilot Study by LOVRE, DRAGANA, KATALENICH, BONNIE, OLMEDA, CARLY CARRION, CAMITTA, SARAH B., KHAN, AMNA N., FONSECA, VIVIAN, THETHI, TINA K.

“…The GLP-1 receptor agonists have been shown to decrease blood pressure (BP) in clinical trials using office BP measurements. However, the effect of GLP-1…”
Get full text

Comparison of weight loss data collected by research technicians versus electronic medical records: the PROPEL trial by Katzmarzyk, Peter T., Mire, Emily F., Martin, Corby K., Newton, Robert L., Apolzan, John W., Price-Haywood, Eboni G., Denstel, Kara D., Horswell, Ronald, Chu, San T., Johnson, William D.

“…Background/objectives Pragmatic trials are increasingly used to study the implementation of weight loss interventions in real-world settings. This study…”
Get full text

Evaluation of a Remote Monitoring System for Diabetes Control by Katalenich, Bonnie, MPH, Shi, Lizheng, PhD, MS, Liu, Shuqian, MD, Shao, Hui, MHA, McDuffie, Roberta, MSN, Carpio, Gandahari, MD, Thethi, Tina, MD, MPH, Fonseca, Vivian, MD

“…Abstract Purpose The use of technology to implement cost-effective health care management on a large scale may be an alternative for diabetes management but…”
Get full text